ATE449323T1 - Zum nachweisen von erkrankungen der brust geeignete reagenzien und verfahren - Google Patents
Zum nachweisen von erkrankungen der brust geeignete reagenzien und verfahrenInfo
- Publication number
- ATE449323T1 ATE449323T1 AT02782132T AT02782132T ATE449323T1 AT E449323 T1 ATE449323 T1 AT E449323T1 AT 02782132 T AT02782132 T AT 02782132T AT 02782132 T AT02782132 T AT 02782132T AT E449323 T1 ATE449323 T1 AT E449323T1
- Authority
- AT
- Austria
- Prior art keywords
- reagents
- methods used
- detecting breast
- breast diseases
- diseases
- Prior art date
Links
- 208000030270 breast disease Diseases 0.000 title 1
- 239000003153 chemical reaction reagent Substances 0.000 title 1
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4721—Lipocortins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3015—Breast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4713—Plasma globulins, lactoglobulin
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/975,502 US20030044859A1 (en) | 1996-08-19 | 2001-10-11 | Reagents and methods useful for detecting diseases of the breast |
PCT/US2002/032152 WO2003031942A1 (en) | 2001-10-11 | 2002-10-10 | Reagents and methods useful for detecting diseases of the breast |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE449323T1 true ATE449323T1 (de) | 2009-12-15 |
Family
ID=25523097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02782132T ATE449323T1 (de) | 2001-10-11 | 2002-10-10 | Zum nachweisen von erkrankungen der brust geeignete reagenzien und verfahren |
Country Status (7)
Country | Link |
---|---|
US (2) | US20030044859A1 (de) |
EP (1) | EP1451552B1 (de) |
JP (1) | JP4287275B2 (de) |
AT (1) | ATE449323T1 (de) |
CA (1) | CA2462900A1 (de) |
DE (1) | DE60234465D1 (de) |
WO (1) | WO2003031942A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8034920B2 (en) * | 1997-10-31 | 2011-10-11 | Abbott Laboratories | Nucleic acid primers and probes for detecting breast cells |
DE602004015037D1 (de) * | 2003-05-01 | 2008-08-28 | Veridex Llc | Intraoperativer Lymphknotentest |
GB0320648D0 (en) * | 2003-09-03 | 2003-10-01 | Randox Lab Ltd | Molecular marker |
US7662580B2 (en) * | 2005-11-10 | 2010-02-16 | Aurelium Biopharma Inc. | Tissue diagnostics for breast cancer |
US20070130694A1 (en) * | 2005-12-12 | 2007-06-14 | Michaels Emily W | Textile surface modification composition |
AU2009205956B2 (en) | 2008-01-18 | 2015-07-02 | President And Fellows Of Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
US8980269B2 (en) | 2009-07-14 | 2015-03-17 | Temple University Of The Commonwealth System Of Higher Education | G-protein coupled receptor-associated sorting protein 1 as a cancer biomarker |
EP2727935A3 (de) * | 2009-07-14 | 2014-07-30 | Temple University Of The Commonwealth System Of Higher Education | Mit Frühstadium und anderen Stadien von Brustkrebs assoziierte Serummarker |
WO2012012717A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting prenatal or pregnancy-related diseases or conditions |
CN103124795A (zh) * | 2010-07-23 | 2013-05-29 | 哈佛大学校长及研究员协会 | 利用吞噬细胞检测疾病或病症的方法 |
EP2596116A4 (de) | 2010-07-23 | 2014-03-19 | Harvard College | Verfahren zur erkennung von autoimmun- oder autoimmunbezogenen erkrankungen oder leiden |
NZ771629A (en) | 2013-03-09 | 2022-12-23 | Harry Stylli | Methods of detecting cancer |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5254458A (en) * | 1987-10-30 | 1993-10-19 | Abbott Laboratories | Immunoassays using antigens produced in heterologous organisms |
US5668267A (en) * | 1995-05-31 | 1997-09-16 | Washington University | Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein |
US6379671B1 (en) * | 1996-08-19 | 2002-04-30 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the breast |
CA2269634C (en) * | 1996-10-31 | 2010-08-17 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the breast |
JP2003523171A (ja) * | 1999-01-19 | 2003-08-05 | アボット・ラボラトリーズ | 乳房の疾患を検出するために有用な試薬と方法 |
US20020082216A1 (en) * | 2000-05-26 | 2002-06-27 | Fanger Gary R. | Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
JP2003502028A (ja) * | 1999-05-28 | 2003-01-21 | コリクサ コーポレイション | 乳癌の治療、診断およびモニタリングのための組成物および方法 |
US20030059432A1 (en) * | 2000-02-11 | 2003-03-27 | Dillon Davin C. | Lipophilin complexes for use in cancer diagnosis and therapy |
ATE353974T1 (de) * | 2000-04-03 | 2007-03-15 | Corixa Corp | Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs |
-
2001
- 2001-10-11 US US09/975,502 patent/US20030044859A1/en not_active Abandoned
-
2002
- 2002-10-10 EP EP02782132A patent/EP1451552B1/de not_active Expired - Lifetime
- 2002-10-10 JP JP2003534875A patent/JP4287275B2/ja not_active Expired - Fee Related
- 2002-10-10 WO PCT/US2002/032152 patent/WO2003031942A1/en active Application Filing
- 2002-10-10 DE DE60234465T patent/DE60234465D1/de not_active Expired - Lifetime
- 2002-10-10 CA CA002462900A patent/CA2462900A1/en not_active Abandoned
- 2002-10-10 AT AT02782132T patent/ATE449323T1/de not_active IP Right Cessation
-
2004
- 2004-04-01 US US10/816,326 patent/US20040265932A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003031942A1 (en) | 2003-04-17 |
JP2005524053A (ja) | 2005-08-11 |
US20040265932A1 (en) | 2004-12-30 |
EP1451552A4 (de) | 2006-06-28 |
EP1451552B1 (de) | 2009-11-18 |
CA2462900A1 (en) | 2003-04-17 |
WO2003031942A8 (en) | 2003-11-13 |
US20030044859A1 (en) | 2003-03-06 |
JP4287275B2 (ja) | 2009-07-01 |
EP1451552A2 (de) | 2004-09-01 |
DE60234465D1 (de) | 2009-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE271691T1 (de) | Verfahren zum nachweis der effektivität einer krebstherapie | |
DE60223635D1 (de) | Reagenzien, Verfahren und Vorrichtungen zum Nachweis von Analyten | |
DE60304755D1 (de) | Vorrichtung zur Bestimmung von Thrombosen tiefliegender Venen | |
DE60035719D1 (de) | Vorrichtung zur ermittlung von herzrate und anormaler beatmung | |
IS6217A (is) | Mótefnissameindir með sérvirkni fyrir alfa æxlisdrepboða í mönnum og notkun þeirra | |
DE60228160D1 (de) | System und Verfahren zum Durchführen von drahtlosen Transaktionen | |
DE602004031649D1 (de) | Verfahren und gerät zum nachweis und zur diskriminierung von arrhythmien | |
DE60334664D1 (de) | System und Verfahren zum Nachweis von biologischem und chemischem Material | |
ATE449323T1 (de) | Zum nachweisen von erkrankungen der brust geeignete reagenzien und verfahren | |
DE602004019812D1 (de) | Marker für neuromyelitis optica | |
DE602004028513D1 (de) | Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern | |
DE60306920D1 (de) | Vorrichtung zur bestimmung der feinheit von mineralfasern | |
DE60323875D1 (de) | Eine atp-rückzykluslänge verwendende vorrichtung zur unterscheidung von arrythmien | |
DE60133982D1 (de) | Biosensor und verfahren zum analysieren von blutkomponenten | |
DE50213709D1 (de) | Verfahren zur bereitstellung von zielführungshinweisen | |
DE60214645D1 (de) | Vorrichtung zum Detektieren von magnetischer Flüssigkeit | |
ATE401421T1 (de) | Verfahren zum nachweis von dna methylierung | |
ATE426043T1 (de) | Verfahren zur identifizierung des brustkrebsrisikos | |
DE50205380D1 (de) | Vorrichtung zum erfassen und darstellen von bewegungen | |
DE60142485D1 (de) | Verfahren zur Beurteilung von zellulären proliferativen Erkrankungen | |
DE50203510D1 (de) | Verfahren zur erkennung und identifizierung von objekten | |
DE60238374D1 (de) | Vorrichtung und verfahren zum unterirdischen indizieren | |
DE60217652D1 (de) | Kit und verfahren zum nachweis von fäkalen parasiten | |
SE0200214D0 (sv) | Vorrichtung zur Anzeige von Nutzerinformationen | |
ATE408832T1 (de) | Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |